Common mechanisms of melanoma progression and treatment resistance

The common mechanisms of melanoma progression and treatment resistance. PI3K/AKT/mTOR and RAS/RAF/MEK/ERK pathways are the most characterized tumor growth/treatment resistance-driving signals in melanoma. The activation of PI3K/AKT/mTOR is tightly controlled via a multistep process that can be initiated through tyrosine kinase receptors (RTKs) such as IGF-1R. The stimulation of IGF-1R by its ligand triggers the activation of PI3K via their catalytic (p110) and regulatory (p85) subunits leading to the conversion of phosphatidylinositol (3,4)-bisphosphate (PIP2) lipids to phosphatidylinositol (3,4,5)-trisphosphate (PIP3) allowing PDK1 to phosphorylate the tyrosine 308 (T308) residue and mTORC2 to phosphorylate tyrosine 473 (T473) in the activation loop of AKT. Activated AKT then activates mTORC1 that, in turn, enhances the activation of the eukaryotic translation initiation factor 4E binding protein 1 (4EBP1), and ribosomal protein S6 kinase (S6K). The activation of the Ras/RAF/MEK/ERK signaling pathway is mediated by the stimulation of epidermal growth factor (EGF) by its ligand for BRAF wild type or by active mutation in the cells bearing a NRAS mutation. The treatment of melanoma cells bearing BRAFV600E with specific inhibitors (e.g., dabrafenib) stimulates melanoma cells to overcome the inhibitory effect of BRAF through the generation of BRAF isoforms via alternative splicing. Treatment of patients with a NRAS mutation (NRASQ61R) with MEK inhibitors (e.g., trametinib) generates ERK negative feedback effects on RAS, which creates a bypass mechanism through activation of ARAF and/or CRAF to replace functional BRAF
Common mechanisms of melanoma progression and treatment resistance

Publication

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells (2024) Youssef Al Hmada, et al. Cancers (Basel). 2024 Jan;16(2). Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates EGFR EGFR ncbigene_symbol EGFR 1956
Homo sapiens Primates NRAS NRAS ncbigene_symbol NRAS 4893
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CA 5290
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CB 5291
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CD 5293
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CG 5294
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R3 8503
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R4 30849
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R5 23533
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R6 146850
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R1 5295
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R2 5296
Homo sapiens Primates PSS PSS ncbigene_symbol PSS 780904
Homo sapiens Primates PSS PSS ncbigene_synonym CDSN 1041
Homo sapiens Primates P110 P110 ncbigene_synonym CUX1 1523
Homo sapiens Primates P110 P110 ncbigene_synonym SART3 9733
Homo sapiens Primates CRAF CRAF ncbigene_synonym RAF1 5894
Homo sapiens Primates BRAF BRAF ncbigene_symbol BRAF 673
Homo sapiens Primates AKT AKT ncbigene_synonym AKT1 207
Homo sapiens Primates AKT AKT famplex_relations AKT2 208
Homo sapiens Primates AKT AKT famplex_relations AKT3 10000
Homo sapiens Primates MEK1/2 MEK2 ncbigene_synonym MAP2K2 5605
Homo sapiens Primates MEK1/2 MEK1 ncbigene_synonym MAP2K1 5604
Homo sapiens Primates mTORC2 MTORC2 famplex_relations MAPKAP1 79109
Homo sapiens Primates mTORC2 MTORC2 famplex_relations MTOR 2475
Homo sapiens Primates mTORC2 MTORC2 famplex_relations RICTOR 253260
Homo sapiens Primates mTORC2 MTORC2 famplex_relations MLST8 64223
Homo sapiens Primates ERK1 ERK1 ncbigene_synonym MAPK3 5595
Homo sapiens Primates ERK1/2 ERK2 ncbigene_synonym MAPK1 5594
Homo sapiens Primates mTORC1 MTORC1 famplex_relations RPTOR 57521
Homo sapiens Primates 4E-BP1 4E-BP1 ncbigene_synonym EIF4EBP1 1978
Homo sapiens Primates S6K S6K ncbigene_synonym RPS6KB1 6198

Chemical mentions

Word Match MeSH Name ChEBI
Dabrafenib dabrafenib N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide chebi:75045
Trametinib trametinib N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide chebi:75998

Disease mentions

Word Match MeSH Name DOID
Melanoma melanoma melanoma DOID:1909